Breaking News
April 20, 2018 - College students with autism have high rate of suicidal thoughts
April 20, 2018 - Study sheds light on how the HSC niche is maintained
April 20, 2018 - Drug test spurs frank talk between hypertension patients and doctors
April 19, 2018 - Low-cost deworming drug improves female farmers’ physical fitness
April 19, 2018 - Genome editing identifies neural circuit behind leptin’s anti-obesity and anti-diabetes effects
April 19, 2018 - Many European countries lack comprehensive policy to eliminate viral hepatitis
April 19, 2018 - Young people with ADHD ‘more likely’ to come from deprived neighbourhoods
April 19, 2018 - SLU professor discovers new biomarkers for chlorine gas exposure
April 19, 2018 - Study proposes new mechanism that may contribute to gender differences in weight control
April 19, 2018 - Sleep restriction therapy does not interfere with insomnia patient’s driving ability, research shows
April 19, 2018 - Deep brain stimulation offers relief to UTHealth patient with treatment-resistant depression
April 19, 2018 - Study shows fatty fish and camelina oil boost HDL and IDL cholesterol
April 19, 2018 - FDA Alert: Euphoric Capsules by Epic Products: Recall
April 19, 2018 - Researchers identify peptide produced during cartilage deterioration as a potential source of osteoarthritis pain
April 19, 2018 - New breakthrough may allow scientists to orchestrate tissue regeneration in humans
April 19, 2018 - SYGNIS AG introduces new TruePrime apoptotic cell free DNA amplification kit
April 19, 2018 - Innovative device shows promise in capturing and releasing circulating tumor cells
April 19, 2018 - Researchers shed light on role of striosomal neurons in reinforcement learning
April 19, 2018 - Genetic make-up impacts long-term effectiveness of phobia treatment
April 19, 2018 - Novel biomarker can distinguish malignant lung nodules
April 19, 2018 - Study reports promising novel approach to treat therapy resistant pediatric brain tumors
April 19, 2018 - One-Hour Plasma Glucose Useful Predictor of Diabetic Retinopathy
April 19, 2018 - Hydroxychloroquine no more effective than placebo for relieving osteoarthritis hand pain
April 19, 2018 - Transplanted livers have a protective effect and reduce potential for organ rejection
April 19, 2018 - Researchers develop new method to study activity of inflammatory cells
April 19, 2018 - Researchers discover highly antibiotic resistant superbugs in Gulf States
April 19, 2018 - Interaction between dioxin and HLA gene variant activates events associated with rheumatoid arthritis
April 19, 2018 - Eyes of adolescents could be associated with increased risk of cardiovascular disease in later life
April 19, 2018 - U.S. Women Less Likely Than Men to Get Statins After Heart Attack
April 19, 2018 - Health Canada grants cannabis cultivation license to High Park Farms
April 19, 2018 - Atypical brain development observed in preschoolers with ADHD symptoms
April 19, 2018 - SC Johnson releases annual Sustainability Report
April 19, 2018 - Positive attitudes about aging reduce risk of dementia in older adults
April 19, 2018 - Environmental pollutants found to worsen rheumatoid arthritis
April 19, 2018 - UT Southwestern scientists discover protein linked to metastatic breast cancer
April 19, 2018 - Study highlights need for further evidence to improve symptom management in end of life care
April 19, 2018 - Detecting diminished dopamine-firing cells inside brain could reveal earliest signs of Alzheimer’s
April 19, 2018 - Uniqsis offers high-power LED light unit for scalable flow photochemistry reactions
April 19, 2018 - Case study shows how intravascular ultrasound imaging helps detect acute aortic syndrome
April 19, 2018 - Research reveals new mechanism by which HIV evades the immune system
April 19, 2018 - Nanodisc-delivered cancer treatment helps eliminate tumors
April 19, 2018 - Functional connectivity MRI could help detect brain disorders and diseases
April 19, 2018 - Finding better way to quantify neuropathy symptoms and treatment efficacy
April 19, 2018 - Study examines effectiveness of caregiver education about sickle cell trait
April 19, 2018 - High-resolution images of tumor vasculature using new technology
April 19, 2018 - Lack of sleep may be linked to risk factor for Alzheimer’s disease
April 19, 2018 - Study finds neurotransmitter may play a role in alcohol relapse, addiction
April 19, 2018 - Researchers build molecular networks of calcific aortic valve disease
April 19, 2018 - Researchers develop highly specific apoptosis assay for pharmacodynamic analyses of tumor specimens
April 19, 2018 - Scientists decipher mechanism of chemotherapy induced female infertility
April 19, 2018 - New insight may allow researchers to design drugs that improve immune responses to vaccines
April 19, 2018 - FDA Approves Crysvita (burosumab-twza) for X-Linked Hypophosphatemia
April 19, 2018 - Researchers uncover origin of virus-fighting plasma B cells
April 19, 2018 - Study finds no evidence of lower intelligence in young children who had anesthesia
April 19, 2018 - Baboons break out of research facility briefly
April 19, 2018 - Study shows how deployment time increases risk of suicide attempt in soldiers
April 19, 2018 - Specific odors from malaria infected individuals attract more mosquitoes
April 19, 2018 - FDA Alert: Rhino 69 Extreme 50000 by AMA Wholesale: Recall
April 19, 2018 - Top HIV cure research team refutes major recent results on how to identify HIV persistence
April 19, 2018 - Experts propose new solutions to increase benefit, affordability of targeted cancer medicines
April 19, 2018 - Deficiency of innate immune adaptor TRIF shortens survival time of ALS mice
April 19, 2018 - New machine learning method offers better way to detect heart disease
April 19, 2018 - CNIO researchers determine structure of protein complex related to cell survival
April 19, 2018 - Faith-based diabetes support program launched by UTSA research team
April 19, 2018 - Volumetric Laser Endomicroscopy Helps ID Barrett’s Regions
April 19, 2018 - Engineered cartilage template to heal broken bones
April 19, 2018 - New computational framework accurately predicts drug-drug and drug-food interactions
April 18, 2018 - Some human cancers may be result of evolutionary accidents, research finds
April 18, 2018 - Higher levels of education linked to lower dementia risk in older African Americans
April 18, 2018 - Smoking Puts Blacks at Higher Risk for Heart Failure
April 18, 2018 - Physiotherapist contributes to guidelines for knee cartilage treatment
April 18, 2018 - Researchers use ‘top-down proteomics’ strategy to get new insights into cancer
April 18, 2018 - Physician assistants less likely to accurately diagnose early stage skin cancers
April 18, 2018 - New faster, streamlined method for bowel cancer detection and treatment
April 18, 2018 - Researchers identify new Listeria species in Costa Rica
April 18, 2018 - Novel interactive diagram shows many facets of mild traumatic brain injury
April 18, 2018 - Short sleep linked to obesity in children and adolescents
April 18, 2018 - When weight loss helps with sleep
April 18, 2018 - New mathematical model can predict efficiency of microbiome therapies
April 18, 2018 - People with high LDL cholesterol levels likely to get greater benefits from statins
Two immunotherapy approaches for multiple myeloma show hope

Two immunotherapy approaches for multiple myeloma show hope

image_pdfDownload PDFimage_print

Researchers from the University of Pennsylvania’s Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.

Multiple myeloma is a cancer of the bone marrow. healthy plasma cells in the bone marrow mutate and multiply uncontrollably. malignant plasma cells produce a paraprotein. Image Credit: Designua / Shutterstock

Multiple myeloma is a cancer of the bone marrow. healthy plasma cells in the bone marrow mutate and multiply uncontrollably. malignant plasma cells produce a paraprotein. Image Credit: Designua / Shutterstock

The other study used a monoclonal antibody in treatment of multiple myeloma. Both of the studies would be presented as oral abstracts at the 59th Annual American Society of Hematology Meeting and Exposition in Atlanta.

The team of researchers administered CAR T cells to the multiple myeloma patients after they had undergone chemotherapy and found that 64 percent of the patients responded favorably after the therapy. In the other study an experimental monoclonal antibody was infused into patients with resistant multiple myeloma and an overall response rate of 60 percent was noted. According to the researchers that receptor targeted in both these immunotherapy approaches is called the B-Cell Maturation Antigen (BCMA). BCMA occurs in high abundance in patients with myeloma and thus can be used as a target for these drugs in multiple myeloma.

Multiple myeloma affects thousands of patients every year. According to the American Cancer Society the estimated number of new cases this year is around 30,200 and these patients are usually treated with chemotherapy, radiation therapy and stem cell transplant. Multiple myeloma affects particular immune cells called the plasma cells that become cancerous and multiply uncontrollably.

Study 1

The first study is presented as Abstract #505 which involves the use of CART-BCMA. Here the CAR T cells are developed specially by the researchers in collaboration with Novartis over the past five years. Patient’s own immune cells are collected and they are modified in such a manner so that they can find and destroy the cancer cells specifically. These are termed “hunter” cells that can target the BCMA receptor that is present over the cancer cells and can multiply within the body to kill the cancer cells. The normal white blood cells are suppressed first using a chemotherapy cycle before infusing these CAR-T cells. The patients included in the experimental clinical trial had all failed with traditional treatment before being enrolled for the study. On an average they had received some seven lines of therapy before this study and failed to respond adequately.

The group was divided into two dose groups of the CART-BCMA therapy – the lower dose included 5 patients and the higher dosage group had 10 patients. The lower dosage group showed minor response in at least 2 patients. Minor response was defined as 25 percent or more reduction in the levels of myeloma protein. In the higher dosage group, minor response was seen in eight patients (80 percent) and one patient showed complete response. The clinical trial is not yet concluded and more patients are being treated with the higher dose level. Of the 15 patients, side effects such as cytokine-release syndrome which manifests as flu like syndrome, nausea, fever, muscle pain etc. was noted in 12 patients. For this side effect one patient received tocilizumab and another received siltuximab as therapy. No deaths were seen during the study and three patients developed some nerve toxicity that did not persist. Study’s lead author Adam D. Cohen, assistant professor of Hematology and Oncology at Penn and the director of Myeloma Immunotherapy in Penn’s Abramson Cancer Center emphasized the importance of BCMA as an important target in treating multiple myeloma. The study was supported by the Penn-Novartis alliance.

Study 2

The second study presented as Abstract #741 used an experimental drug called GSK2857916. Dr. Cohen led this study as well. This new experimental drug was given breakthrough therapy designation by the US FDA this November so that it could be developed in an expedited fashion. This drug is combination of a chemotherapy drug called MMAF and a monoclonal antibody that targets the BCMA.

For the trial, 35 patients were given 16 treatment cycles with this experimental drug every three weeks. At the end of the study, 21 out of 35 (60 percent) showed some response to the drug. Around 51 percent showed a good partial response which meant that their myeloma protein levels reduced by over 90 percent. Media time that the patient spent without the disease progressing was around eight months.

Significant side effects in this study included eye toxicities such as dry eyes and blurry vision that was seen in 63 percent patients. Cohen added that there was a high response rate which had never been seen among these cases which were unresponsive to routine treatments.

Tagged with:

About author

Related Articles